Balyasny Asset Management L.P. purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,086,812 shares of the company's stock, valued at approximately $43,092,000. Balyasny Asset Management L.P. owned 1.17% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently modified their holdings of the company. JPMorgan Chase & Co. raised its position in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after purchasing an additional 454,044 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Acadia Healthcare by 713.3% during the fourth quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock worth $4,396,000 after acquiring an additional 97,235 shares during the last quarter. Beach Point Capital Management LP acquired a new position in shares of Acadia Healthcare in the fourth quarter worth approximately $14,097,000. Franklin Resources Inc. boosted its holdings in Acadia Healthcare by 273.1% in the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company's stock valued at $6,673,000 after acquiring an additional 77,027 shares during the last quarter. Finally, Sterling Capital Management LLC increased its position in Acadia Healthcare by 59.1% during the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock valued at $216,000 after purchasing an additional 2,026 shares during the period.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on ACHC. Guggenheim began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective on the stock. Bank of America lowered their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. KeyCorp cut their target price on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. Royal Bank of Canada cut their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Finally, Mizuho lowered their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $50.39.
Get Our Latest Analysis on ACHC
Acadia Healthcare Stock Down 1.4 %
Shares of Acadia Healthcare stock traded down $0.35 during trading hours on Friday, reaching $23.87. The company's stock had a trading volume of 1,573,810 shares, compared to its average volume of 1,647,801. The company has a market capitalization of $2.20 billion, a P/E ratio of 7.83, a P/E/G ratio of 1.46 and a beta of 1.01. The stock's fifty day simple moving average is $26.57 and its two-hundred day simple moving average is $36.52. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.